en · de · es
bpc-157-notes.peptides5388.com › Data › Identity And Chemical Background — Quick Reference

Identity And Chemical Background — Quick Reference

By Editorial Desk · published 2026-01-24 · last reviewed 2026-03-13 · Data

acetate salt is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-03-13. Numbers and descriptions here follow the published literature rather than marketing material.

Identity And Chemical Background

BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.

The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.

Background and Research Status

BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.

Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.

Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.

Bpc-157 at a glance

PropertyValueNotes
Molecular formulaC62H98N16O22Approximate, for sequence GEPPPGKPADDAGLV
Molecular mass~1419 DaNeutral form
AppearanceWhite to off-white powderLyophilized solid
SolubilitySoluble in waterAlso soluble in aqueous buffers
Typical storage-20 CDry powder, protected from moisture

Discovery and Research Background

BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.

Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.

Related pages on this site

Identity And Research Background

BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.

The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.

Analysis, Stability, and Handling

Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.

Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.

Research Literature and Evidence Gaps

Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.

Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.

Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.

Further detail

When the Inca people began building a grass suspension bridge, they would first gather natural materials of grass and other vegetation. They would then braid these elements together into rope. This contribution was made by the Inca women. Vast amounts of thin-looking rope were produced. The villagers would then deliver their quota of rope to the builders. The rope was then divided into sections. Each section consisted of an amount of thin rope being laid out together in preparation to create a thicker rope cord. Once the sections are laid out, the strands of rope made earlier are twisted together tightly and evenly, producing the larger and thicker rope cord. These larger ropes are then braided together to create cables, some as thick as a human torso. Depending on the dimensions of the cable, each could weigh up to 200 pounds. These cables were then delivered to the bridge site. It was considered bad luck for women to be anywhere near the construction of the bridge, so the Inca men were therefore in charge of the on-site construction. At the bridge site, a builder(s) would travel to the opposite landmass that they were working to connect. Once they were positioned on the opposite side, one of the thin, light-weight ropes would be thrown over to them. This rope would then be used to pull the main cables over the gorge. Stone beams were built on either side of the gorge and were used in helping to position and secure the cables. The cables were wrapped around these stone beams and tightened inch by inch to decrease any slack in the bridge.

{\displaystyle k_{1}\cdot (PA)^{t}+k_{2}\cdot (PB)^{t}+k_{3}\cdot (PC)^{t}\geq 2{\sqrt {k_{1}k_{2}k_{3}}}\left({\frac {(PD)^{t}}{\sqrt {k_{1}}}}+{\frac {(PE)^{t}}{\sqrt {k_{2}}}}+{\frac {(PF)^{t}}{\sqrt {k_{3}}}}\right).}

Hong Kong has the world's largest number of skyscrapers, with 554 towers taller than 150 metres (490 ft), and the third-largest number of high-rise buildings in the world. The lack of available space restricted development to high-density residential tenements and commercial complexes packed closely together on buildable land. Single-family detached homes are uncommon and generally only found in outlying areas. The International Commerce Centre and Two International Finance Centre are the tallest buildings in Hong Kong and are among the tallest in the Asia-Pacific region. Other distinctive buildings lining the Hong Kong Island skyline include the HSBC Main Building, the anemometer-topped triangular Central Plaza, the circular Hopewell Centre, and the sharp-edged Bank of China Tower.

Sources: en.wikipedia.org

Background from the literature

A position of a codon is said to be a n-fold degenerate site if only n of four possible nucleotides (A, C, G, T) at this position specify the same amino acid. A nucleotide substitution at a 4-fold degenerate site is always a synonymous mutation with no change on the amino acid. A less degenerate site would produce a nonsynonymous mutation on some of the substitutions. An example (and the only) 3-fold degenerate site is the third position of an isoleucine codon. AUU, AUC, or AUA all encode isoleucine, but AUG encodes methionine. In computation, this position is often treated as a twofold degenerate site. A position is said to be non-degenerate if any mutation at this position changes the amino acid. For example, all three positions of methionine's AUG are non-degenerate, because the only codon coding for methionine is AUG. The same goes for tryptophan's UGG. There are three amino acids encoded by six different codons: serine, leucine, and arginine. Only two amino acids are specified by a single codon each. One of these is the amino-acid methionine, specified by the codon AUG, which also specifies the start of translation; the other is tryptophan, specified by the codon UGG.

In the aftermath of World War II, the USAAF consolidated much of its wartime combat force and selected the P-51 as a "standard" piston-engined fighter, while other types, such as the P-38 and P-47, were withdrawn or given substantially reduced roles. As the more advanced (P-80 and P-84) jet fighters were introduced, the P-51 was also relegated to secondary duties. In 1947, the newly formed USAF Strategic Air Command employed fighter Mustangs alongside F-6 Mustangs and F-82 Twin Mustangs, due to their range capabilities. In 1948 a new designation scheme for USAF aircraft was introduced, with the prefix "P-" for "pursuit" changed to "F-" for "fighter" and the existing "F-" designation for photographic reconnaissance replaced with "RF-;" Mustang variants still in service in the USAF or Air National Guard (ANG) when the system was changed included: F-51B, F-51D, F-51K, RF-51D (formerly F-6D), RF-51K (formerly F-6K) and TRF-51D (two-seat trainer conversions of F-6Ds). By 1950, the majority of the USAF's Mustangs had become surplus to requirements and had been placed in storage or transferred to the Air Force Reserve and the ANG.

In classrooms, the requirements in the ASHRAE standard 62.1, Ventilation for Acceptable Indoor Air Quality, would typically result in about 3 air changes per hour, depending on the occupant density. As the occupants are not the only source of pollutants, outdoor air ventilation may need to be higher when unusual or strong sources of pollution exist indoors. ASHRAE Standard 62.1 also provides the Indoor Air Quality Procedure (IAQP), a performance-based alternative to the Ventilation Rate Procedure. Under the IAQP, outdoor airflow and other system design parameters are determined based on factors including contaminant sources, concentration limits, air cleaning, and perceived indoor air acceptability. When outdoor air is polluted, bringing in more outdoor air can actually worsen the overall quality of the indoor air and exacerbate some occupant symptoms related to outdoor air pollution. Generally, outdoor country air is better than indoor city air. The use of air filters can trap some of the air pollutants. Portable room air cleaners with HEPA filters can be used if ventilation is poor or outside air has high level of PM 2.5. Air filters are used to reduce the amount of dust that reaches the wet coils. Dust can serve as food to grow molds on the wet coils and ducts and can reduce the efficiency of the coils. The use of trickle vents on windows is also valuable to maintain constant ventilation. They can help prevent mold and allergen build up in the home or workplace. They can also reduce the spread of some respiratory infections.

Sources: en.wikipedia.org

Further detail

1993/1359) Fresh Meat and Poultry Meat (Hygiene, Inspection and Examinations for Residues) (Charges) (Amendment) Regulations 1993 (S.I. 1993/1360) Pneumoconiosis, Byssinosis and Miscellaneous Diseases Benefit (Amendment) Scheme 1993 (S.I. 1993/1363) Combined Probation Areas (Devon) Order 1993 (S.I. 1993/1364) Barnet, Camden and Westminster (London Borough Boundaries) Order 1993 (S.I. 1993/1365) Crop Residues (Burning) Regulations 1993 (S.I. 1993/1366) Local Government Superannuation (Local Commissioners) Regulations 1993 (S.I. 1993/1367) National Health Service (Fund-Holding Practices) (Scotland) Amendment Regulations 1993 (S.I. 1993/1369) Lancashire County Council (Proposed Connecting Roads to M6 Motorway at Haighton) Special Roads Scheme 1992 Confirmation Instrument 1993 (S.I. 1993/1370) A17 Trunk Road (Leadenham Bypass) Order 1993 (S.I. 1993/1371) A17 Trunk Road (Leadenham Bypass) (Detrunking) Order 1993 (S.I. 1993/1372) King's Lynn—Newark Trunk Road (Leadenham By-pass and Slip Roads) Order 1973 (Revocation) Order 1993 (S.I. 1993/1373) Registered Restrictive Trading Agreements (Inspection, Copy and Certification) (Fees) Regulations 1993 (S.I. 1993/1376) Greater London and Surrey (County and London Borough Boundaries) (No.4) Order 1993 (S.I. 1993/1391)

== History == Early colorants date to prehistoric times. Human beings were already relying on natural substances, primarily from vegetables, but also from animals, to color their homes and artifacts. Cave drawings like those in Altamira or Lascaux were made in the Ice Age 15,000 to 30,000 years ago. Using pigments for coloration is among the oldest cultural activities of mankind. The important substrates of pre-industrial societies were generally naturally occurring (cotton, silk, wool, leather, paper) and therefore share similarities, since they are primarily saccharide or peptide polymers. The 19th and 20th century in particular saw an expansion in colorant use and production, yielding many pigments and dyes in use today. The availability of strong acidic or alkaline environments like sulphuric acid and synthetic sodium carbonate was crucial in this process. These conditions became possible due to price drops in reagents due to new industrial preparations like the LeBlanc process, where potassium carbonate formerly obtained from ashes was replaced by sodium carbonate. However, many early colorants are no longer produced due to economics, or high toxicity, for example Schweinfurt green (cupric acetate arsenite), Scheele's green (copper(II) arsenite), and Naples yellow (lead antimonate). The late 1850s saw the introduction of the first modern synthetic dyes, which brought more color and variety of color to Europe.

The Metropolitan Police apologises to antisemitism charity leader Gideon Falter, who was threatened with arrest by one of its officers for being near a pro-Palestinian march on 13 April, and who was described by the officer as being "openly Jewish". The Grade II listed, 16th-century Burn Bullock, a former coaching inn, is badly damaged by fire. 20 April Chris Stark, head of the Climate Change Committee, tells the BBC that Rishi Sunak has "set us back" on climate change, in contrast to the progress made under Theresa May and Boris Johnson. In response, a government spokesperson says: "We are the first major economy to halve greenhouse gas emissions since 1990 and have set into law one of the most ambitious 2035 climate change targets of any major economy". Co-op Live, the UK's largest indoor arena seating 23,500 and costing £365m to build, opens in Manchester. The venue is forced to apologise, however, after cancelling some tickets to a test gig with Rick Astley and offers ticketholders affected tickets to another concert. Dr Hilary Cass, the author of a report into gender identity services for young people, says she is "very angry" about "misinformation" spread regarding the report. 21 April – The 2024 London Marathon takes place. 22 April Parliament passes the Safety of Rwanda Bill, with plans to deport the first asylum seekers to Kigali in July. Newsreader Huw Edwards resigns from the BBC, nine months after being suspended following allegations of sexual misconduct and being admitted to hospital with "serious mental health issues".

Sources: en.wikipedia.org

Frequently asked questions

What does the abbreviation BPC-157 stand for?

The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.

Is BPC-157 the same as the gastric protein it is named after?

No. The gastric protein is larger, while BPC-157 is a short fragment sequence. The peptide is produced synthetically for research use. The relationship is one of sequence origin, not chemical identity.

What form is the peptide usually distributed in?

It is most often supplied as a lyophilized powder, frequently as the acetate salt. The powder is reconstituted with water or a buffer before use. Free-base and other salt forms also exist but are less common in catalogs.

Is BPC-157 an approved medicine?

It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.

Network